Inhibition of Interleukin-1β-Stimulated Production of Matrix Metalloproteinases by Hyaluronan via CD44 in Human Articular Cartilage

Arthritis and Rheumatism

Volumn 50, Issue 2, 2004, Pages 516-525

  Julovi, Sohel M ^a   Yasuda, Tadashi ^a   Shimizu, Makoto ^a   Hiramitsu, Teruko ^a   Nakamura, Takashi ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; FLUORESCEIN; HERMES ANTIGEN; HYALURONIC ACID; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; STROMELYSIN; BLOCKING ANTIBODY; INTERLEUKIN 1;

ARTICLE; ARTICULAR CARTILAGE; CONTROLLED STUDY; CYTOCHEMISTRY; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; OSTEOARTHRITIS; PRIORITY JOURNAL; CARTILAGE CELL; CULTURE TECHNIQUE; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; ENZYMOLOGY; IMMUNOLOGY; IN VITRO STUDY; METABOLISM;

ANTIBODIES, BLOCKING; ANTIGENS, CD44; CARTILAGE, ARTICULAR; CHONDROCYTES; CULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DRUG ANTAGONISM; HYALURONIC ACID; INTERLEUKIN-1; MATRIX METALLOPROTEINASES;

EID: 1042290333     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20004     Document Type: Article

References (43)

1. Poole AR. Cartilage in health and disease. In: Koopman WJ, editor. Arthritis and allied conditions: a textbook of rheumatology. 14th ed. Baltimore: Lippincott Williams & Wilkins; 2001. p. 226-84.
2. Woessner JF Jr, Gunja-Smith Z. Role of metalloproteinases in human osteoarthritis. J Rheumatol 1991;18:99-101.
3. Shlopov BV, Lie W-R, Mainardi CL, Cole AA, Chubinskaya S, Hasty KA. Osteoarthritic lesions: involvement of three different collagenases. Arthritis Rheum 1997;40:2065-74.
4. Freemont AJ, Hampson V, Tilman R, Goupille P, Taiwo Y, Hoyland JA. Gene expression of matrix metalloproteinase 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific. Ann Rheum Dis 1997;56:542-9.
5. Shlopov BV, Gumanovskaya ML, Hasty KA. Autocrine regulation of collagenase 3 (matrix metalloproteinase 13) during osteoarthritis. Arthritis Rheum 2000;43:195-205.
6. Freemont AJ, Byers RJ, Taiwo YO, Hoyland JA. In situ zymographic localization of type II collagen degrading activity in osteoarthritic human cartilage. Ann Rheum Dis 1999;58:357-65.
7. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck, C, et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic cartilage. J Clin Invest 1997;99:1534-45.
8. Tetlow LC, Adlam DJ, Woolley DE. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum 2001;44:585-94.
9. Peyron JG. Intraarticular hyaluronan injections in the treatment of osteoarthritis: state-of-the-art review. J Rheumatol 1993;20 Suppl 39:10-5.
10. Homandberg GA, Meyers R, Xie DL. Fibronectin fragments cause chondrolysis of bovine articular cartilage slices in culture. J Biol Chem 1992;267:3597-604.
11. Yasuda T, Poole AR. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway. Arthritis Rheum 2002;46:138-48.
12. Kang Y, Eger W, Koepp H, Williams J, Kuettner K, Homandberg GA. Hyaluronan suppresses fibronectin fragment-mediated damage to human cartilage explant cultures by enhancing proteoglycan synthesis. J Orthop Res 1999;17:858-69.
13. Fukuda K, Dan H, Takayama M, Kumano F, Saitoh M, Tanaka S. Hyaluronic acid increases proteoglycan synthesis in bovine articular cartilage in the presence of interleukin-1. J Pharmacol Exp Ther 1996;277:1672-5.
14. Salter DM, Godolphin JL, Gourlay MS, Lawson MF, Hughes DE, Dunne E. Analysis of human articular chondrocyte CD44 isoform expression and function in health and disease. J Pathol 1996;179:396-402.
15. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990;61:1303-13.
16. Toba T, Mizusawa N, Tajima G, Horiuchu S. Upregulation of CD44 mRNA expression by interleukin-1β in cultured rabbit articular chondrocytes. J Bone Miner Metab 1997;15:84-93.
17. Nishida Y, D Souza AL, Thonar EJ-MA, Knudson W. Stimulation of hyaluronan metabolism by interleukin-1α in human articular cartilage. Arthritis Rheum 2000;43:1315-26.
18. Mikecz K, Dennis K, Shi M, Kim JH. Modulation of hyaluronan receptor (CD44) function in vivo in a murine model of rheumatoid arthritis. Arthritis Rheum 1999;42:659768.
19. Neidhart M, Gay RE, Gay S. Anti-interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2000;43:1719-28.
20. McCourt PA, Ek B, Forsberg N, Gustafson S. Intercellular adhesion molecule-1 is a cell surface receptor for hyaluronan. J Biol Chem 1994;269:30081-4.
21. Davies ME, Dingle JT, Pigott R, Power C, Sharma H. Expression of intercellular adhesion molecule 1 (ICAM-1) on human articular cartilage chondrocytes. Connect Tissue Res 1991;26:207-16.
22. Kienzle G, von Kempis J. Vascular cell adhesion molecule 1 (CD106) on primary human articular chondrocytes functional regulation by cytokines and comparison with intercellular adhesion molecule 1 (CD54) and very late activation antigen 2. Arthritis Rheum 1998;41:1296-305.
23. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986;29:1039-49.
24. Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 1980;102:344-52.
25. Takazono I, Tanaka Y. Quantitative analysis of hyaluronic acid by high-performance liquid chromatography of Streptomyces hyaluronidase digests. J Chromatogr 1984;288:167-76.
26. Shinmei M, Miyauchi S, Machida A, Miyazaki K. Quantitation of chondroitin 4-sulfate and chondroitin 6-sulfate in pathologic joint fluid. Arthritis Rheum 1992;35:1304-8.
27. Dahl LB, Dahl IM, Laurent AE, Granath K. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 1985;44:817-22.
28. Homandberg GA, Ummadi V, Kang H. High molecular weight hyaluronan promotes repair of IL-1β-damaged cartilage explants from both young and old bovines. Osteoarthritis Cartilage 2003;11:177-86.
29. Saklatvala J, Pilsworth LMC, Sarsfield ST, Gavrilovic J, Heath JK. Pig catabolin is a form of interleukin-1: cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein. Biochem J 1984;224:461-6.
30. Billinghurst RC, Wu W, Ionescu M, Reiner A, Dahlberg L, Chen J, et al. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase. Arthritis Rheum 2000;43:664-72.
31. Bonassar LJ, Frank EH, Murray JC, Paguio CG, Moore VL, Lark MW, et al. Changes in cartilage composition and physical properties due to stromelysin degradation. Arthritis Rheum 1995;38:173-83.
32. Kempson GE. Mechanical properties of articular cartilage. In: Freeman MAR, editor. Adult articular cartilage. Tunbridge Wells: Pitman Medical; 1979, p. 333-414.
33. Yasui T, Akatsuka M, Tobetto K, Umemoto J, Ando T, Yamashita K, et al. Effects of hyaluronan on the production of stromelysin and tissue inhibitor of metalloproteinase-1 in bovine articular chondrocytes. Biomedical Res 1992;13:343-8.
34. Shimazu A, Jikko A, Iwamoto M, Koike T, Yan W, Okada Y, et al. Effects of hyaluronic acid on the release of proteoglycan from the cell matrix in rabbit chondrocyte cultures in the presence and absence of cytokines. Arthritis Rheum 1993;36:247-53.
35. Knudson W, Casey B, Nishida Y, Eger W, Kuettner KE, Knudson CB. Hyaluronan oligosaccharides perturb cartilage matrix homeostasis and induce chondrocytic chondrolysis. Arthritis Rheum 2000;43:1165-74.
36. Lisignoli G, Grassi F, Zini N, Toneguzzi S, Piacentini A, Guidolin D, et al. Anti-Fas-induced apoptosis in chondrocytes reduced by hyaluronan: evidence for CD44 and CD54 (intercellular adhesion molecule 1) involvement. Arthritis Rheum 2001;44:1800-7.
37. Chow G, Nietfeld JJ, Knudson CB, Knudson W. Antisense inhibition of chondrocyte CD44 expression leading to cartilage chondrolysis. Arthritis Rheum 1998;41:1411-9.
38. McKee CM, Penno MB, Cowman M, Burdick MD, Strieter RM, Bao C, et al. Hyaluronan fragments induce chemokine gene expression in alveolar macrophages. J Clin Invest 1996;98:2403-13.
39. Fujii K, Tanaka Y, Hübscher S, Saito K, Ota T, Eto S. Crosslinking of CD44 on rheumatoid synovial cells augments interleukin 6 production. Lab Invest 1999;79:1439-46.
40. Henke C, Bitterman P, Roongta U, Ingbar D, Polunovsky V. Induction of fibroblast apoptosis by anti-CD44 antibody: implications for the treatment of fibroproliferative lung disease. Am J Pathol 1996;149:1639-50.
41. Naor D, Nedvetzki S. CD44 in rheumatoid arthritis. Arthritis Res Ther 2003;5:105-15.
42. Listrat V, Ayral X, Patarnello F, Bonvarlet JP, Simonnet J, Amor B, et al. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis Cartilage 1997;5:153-60.
43. Frizziero L, Govoni E, Bacchini P. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study. Clin Exp Rheumatol 1998;16:441-9.